Abstract:ABSTRACT Antimicrobial resistance is one of the greatest challenges to global health. While the development of new antimicrobials can combat resistance, low profitability reduces the number of new compounds brought to market. Elucidating the mechanism of action is crucial for developing new antimicrobials. This can become expensive as there are no universally applicable pipelines. Phenotypic heterogeneity of microbial populations resulting from antimicrobial treatment can be captured through flow cytometric fingerprinting. Since antimicrobials are classified into limited groups, the mechanism of action of known compounds can be used for predictive modeling. We demonstrate a cost-effective flow cytometry approach for determining the mechanism of action of new compounds. Cultures of Actinomyces viscosus and Fusobacterium nucleatum were treated with different antimicrobials and measured by flow cytometry. A Gaussian mixture mask was applied over the data to construct phenotypic fingerprints. Fingerprints were used to assess statistical differences between mechanism of action groups and to train random forest classifiers. Classifiers were then used to predict the mechanism of action of cephalothin. Statistical differences were found among the different mechanisms of action groups. Pairwise comparison showed statistical differences for 35 out of 45 pairs for A. viscosus and for 32 out of 45 pairs for F. nucleatum after 3.5 h of treatment. The best-performing random forest classifier yielded a Matthews correlation coefficient of 0.92 and the mechanism of action of cephalothin could be successfully predicted. These findings suggest that flow cytometry can be a cheap and fast alternative for determining the mechanism of action of new antimicrobials. IMPORTANCE In the context of the emerging threat of antimicrobial resistance, the development of novel antimicrobials is a commonly employed strategy to combat resistance. Elucidating the mechanism of action of novel compounds is crucial in this development but can become expensive, as no universally applicable pipelines currently exist. We present a novel flow cytometry-based approach capable of determining the mechanism of action swiftly and cost-effectively. The workflow aims to accelerate drug discovery and could help facilitate a more targeted approach for antimicrobial treatment of patients.

Real-Time Biosynthetic Reaction Monitoring Informs the Mechanism of Action of Antibiotics

The Development of a Pipeline for the Identification and Validation of Small-Molecule RelA Inhibitors for Use as Anti-Biofilm Drugs.

Monitoring Drug-Protein Interactions in the Bacterial Periplasm by Solution Nuclear Magnetic Resonance Spectroscopy

ADP-MoA: a platform for screening antibiotic activity and their mechanism of action in

New techniques in antibiotic discovery and resistance: Raman spectroscopy

Real-time detection of antibiotic activity by measuring nanometer-scale bacterial deformation

Ribosome-Targeting Antibiotics: Modes of Action, Mechanisms of Resistance, and Implications for Drug Design

The Mechanisms of Action of Ribosome-Targeting Peptide Antibiotics

Mechanistic Insights into Clinically Relevant Ribosome-Targeting Antibiotics

Classification of antimicrobial mechanism of action using dynamic bacterial morphology imaging

Microbial environments confound antibiotic efficacy

Nanomechanical detection of antibiotic-mucopeptide binding in a model for superbug drug resistance

Merging multi-omics with proteome integral solubility alteration unveils antibiotic mode of action

Exploring Structure-Activity Relationships and Modes of Action of Laterocidine

High-throughput metabolomic analysis predicts mode of action of uncharacterized antimicrobial compounds

Real-time Monitoring Β-Lactam/β-lactamase Inhibitor (BL/BLI) Mixture Towards the Bacteria Porin Pathway at Single Molecule Level.

Discovery of antibiotics that selectively kill metabolically dormant bacteria

Unlocking the mechanism of action: a cost-effective flow cytometry approach for accelerating antimicrobial drug development

A Novel Chemical Biology and Computational Approach to Expedite the Discovery of New-Generation Polymyxins Against Life-Threatening Acinetobacter Baumannii

Antibacterial mechanisms identified through structural systems pharmacology